Related Experiment Video
Updated: May 20, 2025

07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
8.8K
Use of the National Cancer Database in Identifying Disparities in Cancer Treatment
Fatima Mubarak1, Emmanuel M Gabriel2, Jade C Bowers3
1Aga Khan University, Karachi, Pakistan.
The American Surgeon
|March 25, 2025
Summary
The National Cancer Database (NCDB) offers valuable insights into cancer care disparities in the US. Researchers must understand its strengths and limitations for accurate analysis of cancer outcomes.
Area of Science:
- Oncology
- Health Services Research
- Biostatistics
Background:
- The National Cancer Database (NCDB) is a significant resource for cancer research in the United States.
- Numerous studies have leveraged the NCDB to investigate disparities in cancer care and patient outcomes.
- Understanding the nuances of the NCDB is crucial for valid research on cancer inequities.
Purpose of the Study:
- To review the strengths of the National Cancer Database (NCDB) for studying cancer disparities.
- To outline the limitations of the NCDB when examining cancer care and outcomes.
- To guide researchers in the effective and critical use of the NCDB for disparity research.
Main Methods:
- Literature review of studies utilizing the NCDB for cancer disparity research.
- Analysis of documented strengths and limitations of the NCDB dataset.
- Synthesis of findings to provide recommendations for researchers.
Main Results:
- The NCDB provides a large, comprehensive dataset on cancer patient care in the US.
- Identified strengths include its extensive patient volume and treatment data.
- Key limitations involve potential data biases and specific patient population representation.
Conclusions:
- The NCDB is a powerful tool for exploring cancer disparities, but its application requires careful consideration of its inherent limitations.
- Researchers should be aware of potential biases and data completeness issues when interpreting NCDB findings.
- Acknowledging the strengths and weaknesses of the NCDB enhances the rigor and validity of cancer disparity research.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
313
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
313
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

